Vivendy Therapeutics
Vivendy Therapeutics is a pharmaceutical company founded in 2006 that focuses on developing enzyme replacement therapy for the treatment of Morbus Morquio (MPS IVA), a rare lysosomal storage disease. They have developed a modified recombinant human N-acetylgalactosamine-6-sulfatase (rhGALNS) that improves enzyme activity and enhances the efficacy of the therapy significantly....
N/A
Technology
N/A
Founded
1-10
Employees
Healthcare InsurTech
Industry
Visual (Placeholder)
Profile Information
Name
Vivendy Therapeutics
Industry
Healthcare InsurTech
Technology
N/A
Location
N/A
Founded
N/A
Employees
1-10
Category
Companies
Contact Information
Website
Email
PharmaNewsSales@informa.com
Phone
N/A
Address
N/A